Precision for Medicine completed the acquisition of Algorics.

Precision for Medicine, a leader in biomarker-driven clinical research and development supporting life sciences companies, completed the acquisition of Algorics, a clinical technologies and biometrics service provider. Financial terms were not disclosed. "The acquisition of Algorics represents a strategic enhancement to our suite of clinical technologies that will enhance our project teams' abilities to monitor and advise our sponsors on the performance of their clinical trials while also enhancing our ability to transform diverse datasets with agility and scale. Algorics' team of biostatisticians and data scientists also fortifies our operational presence in the vitally important Asia-Pacific region further growing our operational footprint," Sofia Baig, Precision for Medicine President.